Product How it works Pricing Blog FAQ About Contact
Roivant Sciences

Roivant Sciences (NASDAQ: ROIV) revenue

Roivant Sciences reported revenue of $8.3m for fiscal 2026, 71.6% less than in fiscal 2025 ($29.1m). Since fiscal 2021 its revenue has fallen by 65.3%, an average decline of 19.1% a year.

Roivant Sciences's revenue has fallen for 2 years in a row, and its best year of the last 6 was fiscal 2022. The biggest drop was in fiscal 2026, −71.6%.

Revenue, in millions of US dollars23.8202155.3202231.5202332.7202429.120258.32026
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2026$8.3m−71.6%−$515.1m−6,235.7%
2025$29.1m−11.2%−$1,003m−3,453.3%
2024$32.7m+3.8%$4,497m13,746.9%
2023$31.5m−43.0%−$906.8m−2,875.9%
2022$55.3m+132.3%−$1,352m−2,444.8%
2021$23.8m—−$1,071m−4,500.5%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Roivant Sciences revenue compared with its sector

By revenue for its latest fiscal year, Roivant Sciences ranks 373rd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Roivant Sciences, −71.6%.

RankCompanyRevenueRevenue growth
371stProthena Corporation Public$9.7m−92.8%
372ndBioage Labs$9.0m—
373rdRoivant Sciences$8.3m−71.6%
374thAclaris Therapeutics$7.8m−58.2%
375thXenon Pharmaceuticals$7.5m—

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Roivant Sciences

How much revenue did Roivant Sciences make in fiscal 2026?
Roivant Sciences reported revenue of $8.3m for fiscal 2026, compared with $29.1m in fiscal 2025.
How much has the revenue of Roivant Sciences fallen?
Between fiscal 2021 and fiscal 2026 it went from $23.8m to $8.3m: 65.3% less, an average decline of 19.1% a year.
What was the best year for revenue at Roivant Sciences?
Of its last 6 fiscal years, fiscal 2022, with $55.3m.
Where does Roivant Sciences rank in its sector by revenue?
It ranks 373rd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Roivant Sciences come from?
From the annual report (Form 10-K) that Roivant Sciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Roivant Sciences files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021. More on Roivant Sciences: the Roivant Sciences page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.